Conference Presentation, Panel
Why Younger People Are Getting Cancer and What We Can Do About It | Future of Health Summit 2024
Milken InstituteDylan Scott, Karen Knudsen, Harlan Levine, Mohit Manrao, Kimryn Rathmell, AmirAli Talasaz
- Screening guidelines are shifting downward, with the American Cancer Society and US Preventive Services Task Force recommending colonoscopy initiation at age 45 and mammography discussions starting at age 40 with screening at age 45.
- Epidemiological data from 2000 to 2020 indicates that 17 of 34 major cancer types are rising in incidence among Gen X and millennials, reaching rates two to three times higher than baby boomers.
- Projections suggest cancer mortality could be reduced by an additional 20 to 30% if existing prevention measures are adopted immediately, though current awareness has not yet translated into widespread behavioral change.
- Future research is expected to identify genetic risk factors for early-onset cancers beyond environmental influences, with insights from exceptional responders likely applicable to the broader population.
- Colorectal cancer rates in youth are predicted to worsen before improving due to high prevalence of advanced adenomas, and delays in scheduling colonoscopies in California currently range from three to nine months.
- Universal application of current screening methods to the general youthful population is expected to yield low diagnostic value due to low baseline risk, necessitating precision strategies like genetic testing and liquid biopsies.
- Blood-based screening integrated into annual physicals is anticipated to transform care similar to HbA1c diabetes management, with future iterations expected to improve detection of pre-cancerous lesions as data accumulates.
- Payers are expected to require evidence of life-preservation efficacy rather than mere detection capability before approving new screening tests, while the US Preventive Services Task Force's 5-7 year review cycle is viewed as too slow for rapid advancements.
- The increasing prevalence of young survivors creates a need for treatments addressing long-term quality of life and a heightened risk of second cancer diagnoses decades later, particularly for those diagnosed at age 20.
- Pediatric regimens often yield better outcomes for young adults with specific cancers like lymphoma, and adding immunotherapy to adult protocols can equalize survival rates.
- Primary care physicians currently lack sufficient awareness of multi-cancer early detection technologies and positive signal interpretation, prompting training initiatives like Project ECHO.
- Barriers to trial participation in community centers currently stand below 2% compared to 5-7% in major centers, with plans to embed trials in community settings and leverage private-public partnerships to ensure diverse demographic representation.
- Scientific knowledge is doubling every 72 days, driving strategies to expand dyad models pairing local doctors with NCI specialists and creating ecosystems for seamless patient movement to academic centers.
- Mobile van initiatives and precision early detection strategies are being deployed to educate underrepresented communities and assess risk in youthful populations where traditional imaging may miss early markers.
- Regulatory and funding landscapes present risks, including potential NIH funding cuts from a new administration and the expectation that long-term effects of environmental exposures faced by Gen X and millennials will take time to fully understand.
- The American Cancer Society and US Preventive Services Task Force have aligned on age reductions based on evidence, with the panel scheduled to review QR code and app-submitted questions regarding factors driving youth cancer rates.